| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |